In just over two weeks, hundreds with gather to help fight for a cure for multiple sclerosis at Smith Wills Stadium in Jackson. The Mississippi MS Society will hold ...

What if you were too young for the place you had no choice but to call home? At 39, Mel moved into a long-term care facility ...

March is Multiple Sclerosis awareness month. M.S. is a disease of the brain and spinal cord that affects almost a million ...

A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...

Dimika V. Cavalier shares details of her long MS diagnosis journey and the eventual acceptance of her new normal.

Cells don’t just follow a rigid script when responding to stress – they’re far more adaptable than we thought. A new study ...

The trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability ...